Literature DB >> 28420810

Brain Tumor Registry of Japan (2005-2008).

.   

Abstract

Mesh：

Year:  2017        PMID： 28420810      PMCID： PMC6760096          DOI： 10.2176/nmc.sup.2017-0001

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN： 0470-8105            Impact factor:   1.742


× No keyword cloud information.
  39 in total

1.  Pediatric intracranial lower cranial nerve schwannoma unassociated with neurofibromatosis type 2: case report and review of the literature.

Authors:  Daisuke Hirokawa; Kenichi Usami; Sukwoo Hong; Hideki Ogiwara
Journal:  Childs Nerv Syst       Date:  2019-01-13       Impact factor: 1.475

2.  Feasibility of hippocampal dose-volume parameters associated with memory decline in intensity-modulated radiotherapy for supratentorial tumors.

Authors:  Shigeo Takahashi; Masahide Anada; Toshifumi Kinoshita; Takamasa Nishide; Shohei Kozai; Toru Shibata
Journal:  Mol Clin Oncol       Date:  2021-01-21

Review 3.  Protein Tyrosine Phosphatase Receptor Type Z in Central Nervous System Disease.

Authors:  Kenichiro Nagai; Masazumi Fujii; Shinobu Kitazume
Journal:  Int J Mol Sci       Date:  2022-04-16       Impact factor: 6.208

4.  12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.

Authors:  Kaishi Satomi; Hirokazu Takami; Shintaro Fukushima; Satoshi Yamashita; Yuko Matsushita; Yoichi Nakazato; Tomonari Suzuki; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga; Keiichi Kobayashi; Motoo Nagane; Toshihiko Iuchi; Koji Yoshimoto; Kaoru Tamura; Taketoshi Maehara; Keiichi Sakai; Kazuhiko Sugiyama; Kiyotaka Yokogami; Hideo Takeshima; Masahiro Nonaka; Akio Asai; Toshikazu Ushijima; Masao Matsutani; Ryo Nishikawa; Koichi Ichimura
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

5.  The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.

Authors:  Hideo Nakamura; Hirokazu Takami; Takaaki Yanagisawa; Toshihiro Kumabe; Takamitsu Fujimaki; Yoshiki Arakawa; Katsuyuki Karasawa; Keita Terashima; Hideaki Yokoo; Kohei Fukuoka; Yukihiko Sonoda; Kaori Sakurada; Yohei Mineharu; Toshinori Soejima; Motoaki Fujii; Naoki Shinojima; Junichi Hara; Kai Yamasaki; Junya Fujimura; Fumiyuki Yamasaki; Mayu Takahashi; Tomonari Suzuki; Iori Sato; Ryo Nishikawa; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

6.  Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.

Authors:  Hiroyuki Sasano; Keigo Shikishima; Manabu Aoki; Tsutomu Sakai; Yuki Tsutsumi; Tadashi Nakano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-03       Impact factor: 3.117

7.  Leptomeningeal metastases arising from gynecological cancers.

Authors:  Hiroko Yano; Shoji Nagao; Satoshi Yamaguchi
Journal:  Int J Clin Oncol       Date:  2019-10-04       Impact factor: 3.402

8.  Frequent Clinical and Radiological Progression of Optic Pathway/Hypothalamic Pilocytic Astrocytoma in Adolescents and Young Adults.

Authors:  Takuhiro Shoji; Masayuki Kanamori; Ryuta Saito; Yuko Watanabe; Mika Watanabe; Miki Fujimura; Yoshikazu Ogawa; Yukihiko Sonoda; Toshihiro Kumabe; Shigeo Kure; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-05-14       Impact factor: 1.742

9.  Do TRIB1 and IL-9 Gene Polymorphisms Impact the Development and Manifestation of Pituitary Adenoma?

Authors:  Tomas Mickevicius; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study.

Authors:  Shinji Kawabata; Minoru Suzuki; Katsumi Hirose; Hiroki Tanaka; Takahiro Kato; Hiromi Goto; Yoshitaka Narita; Shin-Ichi Miyatake
Journal:  Neurooncol Adv       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.